Kidney Disease News and Research

RSS

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydrochloride ophthalmic solution, an investigational therapy for the treatment of corneal cystine crystals in patients with cystinosis. The FDA also granted the NDA Priority Review status, a designation given to drugs that may provide major advances or a treatment where no adequate therapy exists.

18 May 2010

Tests of kidney function, damage predict risk of death from cardiovascular diseases: Study

Common tests of kidney function and damage predict the risk of death from cardiovascular diseases and all causes, according to a paper from the Chronic Kidney Disease Prognosis Consortium, established last year by Kidney Disease: Improving Global Outcomes.

18 May 2010

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

18 May 2010

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.

17 May 2010

Better health care for the indigenous population

A report from Melbourne University says that Indigenous Australians are six times more likely than other Australians to be blind and more than a third of this population has never had an eye examination. Now a substantial number of optometrists will be sent to remote Aboriginal communities under a $6.5 million federal program.

16 May 2010

Do Something World Festival wraps up week-long campaign of volunteer service

California Pastor Miles McPherson returned to the Caribbean this week with a large team of volunteers to "do something" for the region. McPherson, a former NFL Player, Senior Pastor of the Rock Church, San Diego and founder of Miles Ahead has produced the Cayman Islands "Do Something World Festival," to take place May 14-15.

15 May 2010

Medco Health Solutions donates $125,000 to U.S. Red Cross for Tennessee flood relief efforts

Medco Health Solutions, Inc.,, on behalf of its affiliated companies and the Medco Foundation, has donated $125,000 to the U.S. Red Cross for relief efforts targeted at victims of recent flooding in Tennessee and other affected areas.

15 May 2010

Hospira's I.V. administration set product line to be standardized to non-DEHP

Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, will expand its commitment to non-DEHP products by transitioning customers to its portfolio of non-DEHP intravenous administration sets.

15 May 2010

Elie Hirschfeld gifts $50,000 to help Roosevelt Hospital's ED Expansion and Redesign Project

A new commitment of $50,000 from Elie Hirschfeld, President and Chief Executive Officer of Hirschfeld Properties and a Trustee of Continuum Health Partners, will help further underwrite Roosevelt Hospital's Emergency Department Expansion and Redesign Project. His gifts to the initiative, to date, total over $150,000.

15 May 2010

CeltiCare to provide high-quality health insurance for Commonwealth Care Bridge Program members

CeltiCare Health Plan of Massachusetts, a Centene Corporation subsidiary, today announced that the state of Massachusetts has renewed its contract to serve Commonwealth Care Bridge Program members, effective July 1, 2010.

15 May 2010

Duchenne Muscular Dystrophy Awareness Week declared to honor work of PPMD

The Pennsylvania House of Representatives has passed a resolution declaring the week of May 24, 2010 as "Duchenne Muscular Dystrophy Awareness Week" to help honor the work of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy.

15 May 2010

Fat tissue different in men and women

The age-old question of why men store fat in their bellies and women store it in their hips may have finally been answered: Genetically speaking, the fat tissue is almost completely different.

15 May 2010

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).

15 May 2010

FDA grants tentative approval for Teva's Cinacalcet HCl Tablets ANDA

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cinacalcet HCl Tablets 30, 60 & 90 mg.

15 May 2010

Research efforts needed to identify optimal treatments for sexual dysfunction in people with CKD

Despite the very high rate of problems with sexual function among people with chronic kidney disease (CKD), little is known about the best treatment approaches in this group of patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

14 May 2010

New cases of Type 1 diabetes in young children to double by 2020: The Lancet

By 2020, new cases of Type 1 diabetes in children younger than five are expected to double if current trends continue, according to a study published in The Lancet. Diabetes is an epidemic, with numbers of those suffering from diabetes and its complications increasing worldwide.

14 May 2010

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

The immunosuppressive drug sirolimus considerably improves the kidney health of patients with autosomal dominant polycystic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

14 May 2010

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

A new class of cancer drugs can be used effectively while minimizing hypertensive side effects if patients' blood pressure is closely monitored and controlled, a clinical panel has determined.

12 May 2010

Routine dental treatment can reduce blood glucose levels in people with type 2 diabetes: Researchers

Routine dental treatment can reduce blood glucose levels in people with type 2 diabetes who have preexisting gum disease.

12 May 2010

Genzyme to initiate $2 billion stock buyback

Genzyme Corp. today announced that its Board of Directors has voted to pursue several actions to increase shareholder value. The company will initiate a $2 billion stock buyback, under which $1 billion of stock will be repurchased in the near term and financed with debt. The additional $1 billion of stock will be repurchased during the next 12 months.

7 May 2010

Kidney Disease News and Research

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Tests of kidney function, damage predict risk of death from cardiovascular diseases: Study

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Better health care for the indigenous population

Do Something World Festival wraps up week-long campaign of volunteer service

Medco Health Solutions donates $125,000 to U.S. Red Cross for Tennessee flood relief efforts

Hospira's I.V. administration set product line to be standardized to non-DEHP

Elie Hirschfeld gifts $50,000 to help Roosevelt Hospital's ED Expansion and Redesign Project

CeltiCare to provide high-quality health insurance for Commonwealth Care Bridge Program members

Duchenne Muscular Dystrophy Awareness Week declared to honor work of PPMD

Fat tissue different in men and women

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

FDA grants tentative approval for Teva's Cinacalcet HCl Tablets ANDA

Research efforts needed to identify optimal treatments for sexual dysfunction in people with CKD

New cases of Type 1 diabetes in young children to double by 2020: The Lancet

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

Routine dental treatment can reduce blood glucose levels in people with type 2 diabetes: Researchers

Genzyme to initiate $2 billion stock buyback

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News